Marie Roskrow
Chairman at LYTIX BIOPHARMA
Net worth: - $ as of 2024-04-29
Profile
Marie Roskrow is currently the Chairman at Lytix Biopharma AS.
Previously, she held the position of Chief Executive Officer, Executive Director & MD at Patrys Ltd.
from 2012 to 2014.
She also served as Chairman & Chief Executive Officer at Helmholtz Zentrum München and ImevaX GmbH.
Additionally, she was the Executive Chairman at ArcticZymes Technologies ASA from 2023 to 2024.
Dr. Roskrow obtained her undergraduate and doctorate degrees from the University of London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-30 | 0 ( -.--% ) | - $ | 2024-04-29 |
Marie Roskrow active positions
| Companies | Position | Start |
|---|---|---|
| LYTIX BIOPHARMA | Chairman | 2023-04-17 |
Former positions of Marie Roskrow
| Companies | Position | End |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Chairman | 2024-05-12 |
| PATRYS LIMITED | Chief Executive Officer | 2014-10-28 |
Helmholtz Zentrum München
 Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Chief Executive Officer | - |
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Chief Executive Officer | - |
Training of Marie Roskrow
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PATRYS LIMITED | Health Technology |
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| Private companies | 2 |
|---|---|
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Health Technology |
Helmholtz Zentrum München
Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Commercial Services |
- Stock Market
- Insiders
- Marie Roskrow